M. Sergeeva-Kondrachenko

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund et al. · The Lancet Diabetes & Endocrinology · 2019 · 342 citations · Full text

Medicine, Nephrology, Pharmacology +13

Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial

Bernard Zinman, Vanita R. Aroda, John B. Buse et al. · Diabetes Care · 2019 · 282 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

Matthias von Herrath, Stephen C. Bain, Bruce W. Bode et al. · The Lancet Diabetes & Endocrinology · 2021 · 178 citations · Full text

Medicine, Endocrinology, Immunology +16

Osteointegration of dental implants in menopausal osteoporosis: optimization strategies, ways and prospects of solving the problem

G. Brudyan, V. Strukov, M. Sergeeva-Kondrachenko et al. · Vrach · 2023 · 10 citations · Full text

Dentistry, Dental Biomaterials Science, Implant Dentistry +17

Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis

Peter Rossing, George L. Bakris, Vlado Perkovic et al. · Diabetes Care · 2025 · 10 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15